Zdrowie i gospodarka · 15/12/2022

FDA Releases Draft Guidance for Developing New Antibacterial Drugs for Pulmonary Tuberculosis Treatment

The US Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on developing new antibacterial drugs to treat pulmonary tuberculosis (TB). The guidance aims to assist sponsors in the clinical development of these new treatments, replacing a previous version published in 2013.